Recently, several studies have found that CDHs can participate in the promotion of tumorigenesis, tumor growth, and malignant progression, and can be exploited for the diagnosis and survival prediction or cancer patients, and even as therapeutic targets [8–10]. Here, PAX3 is linked to neoplasm.